Research and Markets: Contract Research Organization Market in the US 2011-2015

DUBLIN — Research and Markets has announced the addition of the "Contract Research Organization Market in the US 2011-2015" report to their offering.

Contract Research Organization market in the US to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing outsourcing of R&D activities. The Contract Research Organization market in the US has also been witnessing the trend of emerging outsourcing destinations. However, the shortage of CRO staff could pose a challenge to the growth of this market.

The Contract Research Organization Market in the US 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the USA region; it also covers the Contract Research Organization market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Charles River Laboratories International Inc., Covance Inc., Pharmaceutical Product Development Inc., Quintiles Transnational Corp.

Other vendors mentioned in the report: Icon Plc., Ricerca Biosciences LLC, Parexel International , Kendle Inc., and, PharmaNet Clinical Services.

Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
Key Topics Covered:

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

05. Vendor Landscape

06. Buying Criteria

07. Market Growth Drivers

08. Drivers and their Impact

09. Market Challenges

10. Impact of Drivers and Challenges

11. Market Trends

12. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/f69cmh/contract_research

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.